Supersapiens, an Atlanta, GA-based sports continuous glucose monitoring (CGM) company, raised $13.5m in early stage funding.

The round was led by MICA Ventures AG with participation from Ed Baker, former VP of product and growth at Uber and head of international growth at Facebook, Harvey Schwartz, former co-president and CFO of Goldman Sachs, Rémi Duchemin, co-founder of OC Sport, and Eric Min, founder and CEO of Zwift, CM Ventures, Rubix Ventures, Swiss Startup Group, and Wahoo Fitness.

Led by Phil Southerland, founder and CEO, and Todd Furneaux, and co-founder and president, Supersapiens Supersapiens is a sports technology company focused on energy management systems to empower athletes to effectively manage in-training fueling to sustain high-intensity work, properly manage glucose levels to maximize recovery, and achieve bigger performance gains.

Its ecosystem directly integrates with a Bluetooth-enabled CGM  for sports — the Abbott Libre Sense Glucose Sport Biosensor.

The Abbott Libre Sense Glucose Sport Biosensor is intended for athletes to measure glucose. When used with a compatible product, the biosensor allows athletes to correlate their glucose levels and their athletic performance. The biosensor is not intended for use in the diagnosis, treatment, or monitoring of a disease.

In its first 12 weeks on the market, the company has more than 2,000 paying athletes on their system. Supersapiens is working on their first hardware product, a wrist wearable called the Supersapiens Reader Version Zero, which will allow athletes to see their live-streaming fuel data with a quick glance. The device will allow athletes using it to become the first to build a full training and coaching ecosystem around CGM for sports performance.

The ecosystem is now available in Austria, France, Germany, Ireland, Italy, Luxembourg, Switzerland, and the United Kingdom. It is not yet available for sale in the U.S.

Read original article here.